Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Surgery
Share your love
Toku Granted CE and UKCA Marks for CLAiR Technology
Toku announced the acquisition of the CE Mark in Europe and UKCA certification in the United Kingdom for its patented CLAiR technology. This innovation offers a non-invasive method for assessing the risk of cardiovascular disease (CVD) directly at the point…
Negative Effect of Atropine Drops After Glaucoma Surgery
According to a report by an international team of researchers, atropine instillation after trabeculectomy should be discouraged since it causes greater and longer lasting reduction in visual quality.1 The study’s lead author is Panagiotis Laspas, MD, of the Department of…
What Causes Nocturnal Lagophthalmos? | OBN
Nocturnal lagophthalmos is the inability to close the eyelids while sleeping. This can result in a range of conditions from mild epithelial changes to severe exposure ulcers (Katz and Kaufman, 1977). Lagophthalmos is associated with exposure keratopathy, poor sleep, and…
Reginald J. Sanders, M.D. Named as New President of the ASRS
Dr. Reginald J. Sanders, a distinguished physician affiliated with the Retina Group of Washington (RGW) and PRISM Vision Group, has been named as the new president of the American Society of Retina Specialists (ASRS). Dr. Sanders holds the distinction of…
LASIK vs SMILE: Which Options is Right for You?
In the realm of refractive surgery, individuals seeking visual freedom are presented with a plethora of options. Two prominent procedures, SMILE (Small Incision Lenticule Extraction) and LASIK (Laser-Assisted In Situ Keratomileusis), have emerged as front-runners, each with its unique benefits…
Formosa & Cristália Partner for APP13007 Rights in Brazil
Formosa Pharmaceuticals announced a strategic licensing agreement with Cristália Produtos Químicos Farmacêuticos to secure exclusive commercialization rights for APP13007 (clobetasol propionate ophthalmic nanosuspension, 0.05%) in Brazil. APP13007 is designed for the treatment of inflammation and pain following ocular surgery and…
Allotex Receives Funding for Allogeneic Presbyopia Inlays
Allotex and SpA have announced the successful completion of the first close of their $30 million Series B financing. The funds raised will be utilized to further develop their technology aimed at treating refractive errors. The decision to invest in…
OBN Spotlight TV: Interview with Filomena Ribeiro, MD
Ophthalmology Breaking News (OBN) is thrilled to present the first-ever interview with Dr. Filomena Ribeiro as the newly appointed President of the European Society of Cataract and Refractive Surgeons (ESCRS), effective January 1, 2024, succeeding Prof. Oliver Findl. Delve into…
Ocuphire Pharma Gets FDA Nod for Dim Light Visual Acuity Trial
In a recent announcement, Ocuphire Pharma disclosed that it has secured approval from the U.S. Food and Drug Administration (FDA) under a special protocol assessment (SPA) for the clinical trial protocol and planned statistical analysis of its LYNX-2 phase 3…
Promising Treatment for Endothelial Disease
In a groundbreaking study published in The American Journal of Pathology, researchers at Mass Eye and Ear of the Harvard Medical School Department of Ophthalmology have unveiled a novel therapeutic approach using the neuropeptide α-melanocyte–stimulating hormone (α-MSH) to promote corneal…